Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...

Why Democrats’ upset in a Texas state Senate race is a big deal Latest batch of Epstein files has global impact Enormous freshwater reservoir discovered off the East Coast may be 20,000 years old and ...

I’ve spent most of my life caring for others. By 25, I had three children, including premature twins. One was born with severe cerebral palsy – she needed feeding for 12 hours daily in her first year, ...

HIAWATHA — When Kari Martin first brought home Ashtyn — a 19-month-old foster child — he was barely speaking at all, communicating mostly through sounds rather than words. Over the next three years, ...

Therapy notes are private and therapists do not have to share them with you. You can ask for your therapy notes, but your therapist can say no. Therapy notes are not the same as progress notes, which ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Nov 24 (Reuters) - (This Nov 24 story has been corrected to fix the pricing for Zolgensma to $2.5 million from $2.1 million in paragraph 4) The U.S. Food and Drug Administration has approved Novartis' ...

Savannah Lord, the clinical director of a Burlington nonprofit mental health clinic, got an email from Blue Cross Blue Shield of Vermont this month and was immediately alarmed, as were many of her ...

Have you ever felt like your digital notes are more chaos than clarity? Between juggling work tasks, personal reminders, and creative ideas, it’s easy for your notes to spiral into an unmanageable ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) stock was trading lower on Wednesday after the company shared interim results from its ongoing Phase 2 trial of ARCT-032, an investigational inhaled ...

In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of anti-cancer agents—antibody-drug conjugates (ADCs)—can dramatically improve ...